Advisory Board on Radiation and Worker Health, Subcommittee on Dose Reconstruction Review (SDRR) Meeting, 30708-30709 [2020-10892]
Download as PDF
<![CDATA[
30708
Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices
• Miner Safety Branch (CCSB). The
Miner Safety Branch function is to
identify and eliminate safety issues
arising from changing mine conditions
and technologies. State-of-the-art
technologies are used to conduct
fundamental and applied research
aimed at eliminating injuries and
fatalities in mining with a particular
focus on geomechanical instabilities,
localized ground falls, machine safety,
and worker interaction with automated
systems and other emerging
technologies. Researchers specialized in
the fields of geology, geophysics,
seismology, electronic instrumentation,
numerical modeling, geotechnical
engineering, safety engineering, data
science, and mining engineering utilize
state-of-the-art, emerging, and novel
technologies to identify and solve mine
safety challenges. The branch: (1)
Develops, implements, and improves
geophysical methods, geotechnical
instrumentation, and laboratory
techniques through applied research to
quantify rock mass properties and
characterize mining-induced ground
response; (2) utilizes advanced
numerical modeling techniques to better
understand and visualize ground
behavior and support response; (3)
identifies new technologies to monitor
and improve ground support; (4)
conducts research through laboratory
and field assessments of the
performance of engineered support
systems to provide quantifiable design
criteria; (5) develops recommendations
for the design of equipment and
techniques to reduce risks associated
with the installation of ground support;
(6) utilizes experimental and empirical
methods developed through research to
quantify the reliability of alternative
mining methods and design practices;
(7) applies advanced informatics, data
analyses, and visualization techniques
to automated and semi-automated
mining systems to provide increased
situational awareness for mine workers;
(8) assesses, develops and deploys
research-based mine-wide seismic
systems for quantifying and evaluating
seismic hazards and mitigation
strategies for underground and surface
mines; and (9) addresses health and
safety issues that may develop after the
introduction of automated mining
systems and other emerging
technologies in mining.
• Miner Health Branch (CCSC). The
Miner Health Branch function is to
assess and track miner health and
hazard exposures; and develop and
promote health solutions that maximize
worker protection, minimize exposures
and prevent disease, while improving
VerDate Sep<11>2014
17:51 May 19, 2020
Jkt 250001
functional health for the entire mining
population. Research is pursued
through an interdisciplinary approach
involving the fields of epidemiology,
industrial hygiene, occupational
medicine, organizational psychology,
chemistry, as well as mechanical,
electrical, and industrial engineering.
The branch: (1) Incorporates novel and
relevant health surveillance methods for
the systematic assessment of health and
exposure potential of the miner as it
pertains to dynamic mining
environments; (2) conducts research on
the identification and prioritization of
adverse health outcomes and exposures,
and their associated risk factors; (3)
quantitatively and qualitatively
measures risk through research,
experimental, and real-world data
collection; (4) conducts research on the
development and evaluation of
workplace practices and technologies
aimed at preventing injury and illness
that improve long-term functionality for
all miners and benefit employers,
families, and communities; (5) develops
technologies and methods to monitor
and eliminate exposures; and (6)
engages and collaborates across NIOSH
and with industry to effectively
communicate tangible health solutions
and control strategies.
IV. Delegations of Authority: All
delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue with them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Dated: April 29, 2020.
Alex M. Azar, II,
Secretary.
[FR Doc. 2020–10797 Filed 5–19–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2020–0052; NIOSH–337]
Advisory Board on Radiation and
Worker Health, Subcommittee on Dose
Reconstruction Review (SDRR)
Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the
Advisory Board on Radiation and
Worker Health (ABRWH). This meeting
is open to the public, but without an
oral public comment period. The public
is welcome to submit written comments
in advance of the meeting, per the
instructions provided in the address
section below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
audio conference (information below).
The audio conference line has 150 ports
for callers.
DATES: The meeting will be held on July
29, 2020, 10:30 a.m. to 4:00 p.m., EDT.
Written comments must be received
on or before July 24, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0052; NIOSH–337; NIOSH by any of the
following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All information received
in response to this notice must include
the agency name and docket number
[CDC–2020–0052; NIOSH–337]. All
relevant comments received will be
posted without change to https://
www.regulations.gov, including any
personal information provided.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
Meeting Information: Audio
Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1–
866–659–0537; the pass code is
9933701.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090
Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone
(513) 533–6800, Toll Free 1(800)CDC–
INFO, Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\20MYN1.SGM
20MYN1
Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
13889 on March 22, 2020, and will
terminate on March 22, 2022.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
SDRR was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Considered: The agenda
will include discussions on the
following dose reconstruction program
quality management and assurance
activities: Dose reconstruction cases
under review from Set 27, possibly
including cases involving, Amchitka
Island Nuclear Explosion Site, Argonne
National Laboratory, Fee Materials
Production Centers (‘‘Fernald Plant’’),
General Electric—Vallecitos, Hanford,
Idaho National Laboratory, Lawrence
Berkeley National Laboratory, Lawrence
VerDate Sep<11>2014
17:51 May 19, 2020
Jkt 250001
Livermore National Laboratory, Nevada
Test Site, Oak Ridge Gaseous Diffusion
Plant (‘‘K–25’’), Office of Science and
Technology Information (‘‘OSTI’’),
Paducah Gaseous Diffusion Plant,
Portsmouth Gaseous Diffusion Plant,
Savannah River Site, Y–12, and
potentially other Department of Energy
and Atomic Weapons Employers
facilities. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–10892 Filed 5–19–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors
(BSC), National Center for Injury
Prevention and Control (NCIPC). This
meeting is open to the public, limited
only by the ports available. There will
be 2,000 telephone ports available.
There will be 40 minutes allotted for
oral public comments at the end of the
open session from 12:20 p.m. to 1:00
p.m. on July 22, 2020.
The public is encouraged to register to
participate by telephone and/or provide
oral public comment using the
registration form available at the link
provided: https://
www.surveymonkey.com/r/NVV9XM2.
Individuals registered to provide oral
public comment will be called upon to
speak based on the order of registration.
After persons who have registered have
spoken, any remaining time in the oral
SUMMARY:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
30709
public comment period will be used for
members of the public who have not
registered to speak but wish to offer
comment. Individuals making oral
public comment during the meeting will
have a 2-minute speaking limit to allow
for as many comments as possible.
DATES: The meeting will be held on July
22, 2020, 10:00 a.m. to 1:00 p.m., EDT
(OPEN) and July 22, 2020, 1:45 p.m. to
4:15 p.m., EDT (CLOSED).
ADDRESSES: Teleconference 1–800–369–
3110; Participant Code 7563795.
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop S106–9, Atlanta,
GA 30341, Telephone (770) 488–3953,
Email address: NCIPCBSC@cdc.gov.
SUPPLEMENTARY INFORMATION: Portions
of the meeting as designated above will
be closed to the public in accordance
with provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Strategic Business Initiatives Unit,
Office of the Chief Operating Officer,
CDC pursuant to Public Law 92–463.
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
BSC, NCIPC makes recommendations
regarding policies, strategies, objectives,
and priorities; reviews progress toward
injury prevention goals; and provides
evidence in injury prevention-related
research and programs. The Board also
provides advice on the appropriate
balance of intramural and extramural
research, as well as the structure,
progress and performance of intramural
programs. The Board is designed to
provide guidance on extramural
scientific program matters, including
the: (1) Review of extramural research
concepts for funding opportunity
announcements; (2) conduct of
Secondary Peer Review of extramural
research grants, cooperative agreements,
and contracts applications received in
response to the funding opportunity
announcements as they relate to the
E:\FR\FM\20MYN1.SGM
20MYN1
]]>Agencies
[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Pages 30708-30709]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10892]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0052; NIOSH-337]
Advisory Board on Radiation and Worker Health, Subcommittee on
Dose Reconstruction Review (SDRR) Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, but without
an oral public comment period. The public is welcome to submit written
comments in advance of the meeting, per the instructions provided in
the address section below. Written comments received in advance of the
meeting will be included in the official record of the meeting. The
public is also welcome to listen to the meeting by joining the audio
conference (information below). The audio conference line has 150 ports
for callers.
DATES: The meeting will be held on July 29, 2020, 10:30 a.m. to 4:00
p.m., EDT.
Written comments must be received on or before July 24, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0052; NIOSH-337; NIOSH by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: National Institute for Occupational Safety and
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati,
Ohio 45226-1998.
Instructions: All information received in response to this notice
must include the agency name and docket number [CDC-2020-0052; NIOSH-
337]. All relevant comments received will be posted without change to
https://www.regulations.gov, including any personal information
provided. Instructions: All submissions received must include the
Agency name and Docket Number. All relevant comments received in
conformance with the https://www.regulations.gov suitability policy
will be posted without change to https://www.regulations.gov, including
any personal information provided. For access to the docket to read
background documents or comments received, go to https://www.regulations.gov.
Meeting Information: Audio Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1-866-659-0537; the pass code is
9933701.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24,
Cincinnati, Ohio 45226, Telephone (513) 533-6800, Toll Free 1(800)CDC-
INFO, Email [email protected].
SUPPLEMENTARY INFORMATION:
[[Page 30709]]
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and rechartered under Executive Order
13889 on March 22, 2020, and will terminate on March 22, 2022.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. SDRR was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters to be Considered: The agenda will include discussions on
the following dose reconstruction program quality management and
assurance activities: Dose reconstruction cases under review from Set
27, possibly including cases involving, Amchitka Island Nuclear
Explosion Site, Argonne National Laboratory, Fee Materials Production
Centers (``Fernald Plant''), General Electric--Vallecitos, Hanford,
Idaho National Laboratory, Lawrence Berkeley National Laboratory,
Lawrence Livermore National Laboratory, Nevada Test Site, Oak Ridge
Gaseous Diffusion Plant (``K-25''), Office of Science and Technology
Information (``OSTI''), Paducah Gaseous Diffusion Plant, Portsmouth
Gaseous Diffusion Plant, Savannah River Site, Y-12, and potentially
other Department of Energy and Atomic Weapons Employers facilities.
Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-10892 Filed 5-19-20; 8:45 am]
BILLING CODE 4163-18-P
